Region
Silicon Valley-based Scale Asia Ventures raises $30m fund
Scale Asia Ventures (SAV), a Silicon Valley-based investor that aims to bridge the US and Asia start-up ecosystems, has raised USD 30m for its latest early-stage fund.
New Zealand deep-tech VC Pacific Channel seeks co-investors
Pacific Channel, which claims to be the largest deep-tech specialist in New Zealand’s venture capital industry, is seeking co-investors to support maturing portfolio companies that require additional capital.
SPAC backed by Vision Knight founder makes Hong Kong debut
A special purpose acquisition company (SPAC) sponsored by David Wei, founder of Vision Knight Capital, has become the second structure of its kind to list in Hong Kong.
India payments player Kissht closes $80m Series E
Indian payments start-up Kissht has raised a USD 80m Series E round led by Temasek Holdings-owned Vertex Ventures and Brunei Investment Agency.
Singapore cancer treatment start-up gets $126m Series A
Singapore’s Tessa Therapeutics, a biotech developer with a Hodgkin's lymphoma treatment in phase-two trials, has raised a USD 126m Series A round led by US healthcare specialist Polaris Partners.
Med-Fine leads Series A for China's Degron Therapeutics
US and China-based biotech player Degron Therapeutics has closed a USD 22m Series A round led by Med-Fine Capital.
India beauty e-commerce player Purplle achieves unicorn status
India-focused beauty e-commerce platform Purplle has raised USD 33m in funding at a valuation of USD 1.1bn – nearly twice what it was worth about seven months ago.
Korea's Hahn & Co targets $3.25b for Fund IV
Hahn & Company has set a target of USD 3.25bn for its fourth Korea-focused fund, which will include a co-investment sidecar of unspecified size.
Japan personal 'clone' AI start-up gets $26m
Japan’s Alt, an artificial intelligence (AI) developer that personalises deep learning systems to make what it calls digital clones of people, has raised a JPY 3.5b (USD 26m) round featuring Vertex Ventures.
Fengshi leads $45m Series D for China cancer diagnosis player
Singlera Genomics, a Shanghai-based cancer diagnostics specialist, has raised an extended Series B round of CNY 300m (USD 45m) led by Fengshi Investment Management.
China's Insilico Medicine gets $60m Series D
Insilico Medicine, a China-based artificial intelligence (AI)-driven drug discovery company, has raised a USD 60 million Series D round.
Sequoia China leads $210m Series A for Envision Digital
Sequoia Capital China has led a USD 210m Series A round for Envision Digital, a Singapore-based technology developer focused on helping organisations achieve net-zero greenhouse gas emissions.
India edtech start-up gets unicorn status on Series A
PhysicsWallah, an India-based online education platform focused on engineering and medicine, has achieved unicorn status at the Series A stage after raising USD 100m at a post-deal valuation of USD 1.1bn.
DCP hits $2.5b first close on second China fund
DCP Capital has already completed five investments from its second China fund, having completed a first close of USD 2.5bn in January.
China machine vision company AlpsenTek raises $30m
Chinese machine vision developer AlpsenTek has raised a CNY 200m (USD 30m) Series A round led by Xunxing Investment, an arm of mobile brand Oppo, and Cowin Capital.
Japan's Luca Science secures $30m Series B
Luca Science, a Japanese biotech start-up focused on dysfunctional and damaged tissues and organs, has raised a USD 30.3m Series B round led by life sciences specialists 4BIO Capital and DCI Partners.
India's Anicut Capital hits first close on VC fund
Indian early-stage investor Anicut Capital has achieved a first close of INR 1.1bn (USD 14.2m) on its latest VC fund, which is targeting INR 5bn. It coincides with the nomination of a new partner.
China autonomous driving player Minieye raises $120m
Chinese autonomous driving solutions provider Minieye has raised CNY 800m (USD 120m) in Series D funding across three tranches. The third tranche was led by Cathay Capital.
Malaysia's IHH Healthcare sells education arm to Rise Fund
A consortium led by The Rise Fund, TPG’s global impact investment platform, has agreed to acquire the medical education arm of Malaysia-headquartered IHH Healthcare for MYR 1.35bn (USD 306m).
Q&A: Jungle Ventures' Amit Anand
Singapore’s Jungle Ventures has closed its fourth early-stage tech fund on USD 600m, shattering an initial target of USD 350m. Amit Anand, a founding partner at the firm, unpacks the achievement
China secondaries: Liquidity play
Under pressure to generate returns amid a challenging fundraising environment, Chinese GPs are beginning to revise pricing expectations to get traction with continuation funds
Deal focus: Hike supports Song Yao's second act
Orienspace, a Chinese rocket developer founded by the entrepreneur behind DeePhi Technology, has secured USD 60m in funding from Hike Capital and others to accelerate its launch schedule